Sino Biopharmaceutical | 1177 - Ebit


Sino Biopharmaceutical reported CNY5.18B in EBIT for its fiscal semester ending in June of 2025.





Ebit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Avita Medical AUD -6.17M 4.22M Jun/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Jiangsu Hengrui CNY 2.85B 1.17B Sep/2026
Moderna USD -815M 573M Jun/2026
Organon & Co USD 291M 33M Jun/2026
Revvity USD 126.14M 43.36M Jun/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tectonic Therapeutic USD -24.22M 3.08M Jun/2026
Viatris USD 73.7M 93.9M Jun/2026
Xeris Pharmaceuticals USD -24.15M 33.27M Jun/2026